
    
      This study will conduct in 15 sites to enrolled 120 patients with vertigo under 7 days
      treatment and 7 days follow-up. The study includes three arms: high dose, low dose and
      placebo control.To observe the efficacy by change of vertigo severity and duration,and safety
      by vital sign,adverse event,etc.
    
  